World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhou DS, Xu L, Luo YL, He FY, Huang JT, Zhang YJ, Chen MS. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World J Gastroenterol 2015; 21(18): 5582-5590 [PMID: 25987783 DOI: 10.3748/wjg.v21.i18.5582]
URL:	https://www.wjgnet.com/1007-9327/full/v21/i18/5582.htm

(268) (282) (0) (0) (0) (6517) (24)

Number	Citing Articles
1	Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22 doi: 10.1016/j.aohep.2020.08.067
2	Yongzhao Zhao, Guangyan Si, Fengshang Zhu, Jialiang Hui, Shangli Cai, Chenshen Huang, Sijin Cheng, Abdel Hamid Fathy, Yi Xiang, Jing Li. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(14) doi: 10.18632/oncotarget.15281
3	Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059 Abstract(1659) \| Core Tip(1501) \| Full Article(HTML)(6972) \| Full Article (PDF)-1208K(993) \| Full Article (Word)-242K(275) \| Peer-Review Report-109K(373) \| Answering Reviewers-11K(338) \| Times Cited (56) \| Total Visits (9281) \| Open
4	Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10) doi: 10.1007/s00330-020-06931-5
5	Lingling Lu, Kunzhe Lin, Jiaolong Zheng, Haicong Wu, Dongliang Li. Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis. BMJ Open 2021; 11(12) doi: 10.1136/bmjopen-2021-053061
6	Brian I. Carr. Hepatocellular Carcinoma. 2016; doi: 10.1007/978-3-319-34214-6_11
7	Chao-Bin He, Xiao-Jun Lin, Sheng-Nan Lu. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0174769
8	Ying Liu, Menting Shi, Shuanggang Chen, Weiqi Wan, Lujun Shen, Binyan Shen, Han Qi, Fei Cao, Ying Wu, Tao Huang, Guanjian Chen, Jinqing Mo, Dongdong Ye, Yinqi Zhang, Ziqing Feng, Weijun Fan. Intermediate stage hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2021; 17(3) doi: 10.4103/jcrt.jcrt_29_21
9	Yu-chen Wei, Liang yun, Yan-ling Liang, Robert Grimm, Chongze Yang, Yuan-fang Tao, Sheng-chen Jiang, Jin-yuan Liao. Nomogram based on the neutrophil-to-lymphocyte ratio and MR diffusion quantitative parameters for predicting Ki67 expression in hepatocellular carcinoma from a prospective study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-82333-7
10	Xingshun Qi, Jianjun Li, Han Deng, Hongyu Li, Chunping Su, Xiaozhong Guo. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Oncotarget 2016; 7(29) doi: 10.18632/oncotarget.9942
11	Shuxin Sun, Chaobin He, Jun Wang, Xin Huang, Jiali Wu, Shengping Li. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07482-0
12	Liang-He Lu, Wei Wei, Shao-Hua Li, Yong-Fa Zhang, Rong-Ping Guo. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE. Aging 2021; 13(4) doi: 10.18632/aging.202468
13	Shuanggang Chen, Lujun Shen, Han Qi, Pan Hu, Fei Cao, Lin Xie, Yujia Wang, Weijun Fan. Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era. BMJ Open Gastroenterology 2026; 13(1) doi: 10.1136/bmjgast-2025-002154
14	Oren Shibolet, Vito Guerra, Issac Kori, Brian I Carr, Yossi Ventura. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World Journal of Gastroenterology 2018; 24(15): 1641-1649 doi: 10.3748/wjg.v24.i15.1641 Abstract(1493) \| Core Tip(1482) \| Full Article(HTML)(5652) \| Full Article (PDF)-1394K(678) \| Full Article (Word)-527K(335) \| Audio-674K(46) \| Peer-Review Report-79K(319) \| Answering Reviewers-363K(323) \| Times Cited (10) \| Total Visits (8328) \| Open
15	Walid I. Yousif, Mohamed F. Bakosh. Prognostic Impact of Initial Laboratory-based Scores for Hepatocellular Carcinoma Patients: A Retrospective Study. Journal of Clinical and Experimental Hepatology 2025; 15(6) doi: 10.1016/j.jceh.2025.102604
16	Brian I. Carr, Vito Guerra. Serum Albumin Levels in Relation to Tumor Parameters in Hepatocellular Carcinoma Patients. The International Journal of Biological Markers 2017; 32(4) doi: 10.5301/ijbm.5000300
17	Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Teruo Komokata, Teruto Hashiguchi, Yutaka Imoto. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/9142672
18	Zhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, Zhi-Bo Zhang, Kai Wang, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Zhong-Tai Lin, Shu-Qun Li, Yi-Nan Li, Yang-Kai Fu, Mao-Lin Yan. Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery. Liver Cancer 2024; 13(5) doi: 10.1159/000536376
19	Han Cheng, Sandeep Bhushan, Na Li, Zongwei Xiao, Ke Gao. Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor–node–metastasis stages in patients with non-small cell lung cancer. Journal of Cancer Research and Therapeutics 2022; 18(6) doi: 10.4103/jcrt.jcrt_473_21
20	Shaodi Wen, Yuzhong Chen, Chupeng Hu, Xiaoyue Du, Jingwei Xia, Xin Wang, Wei Zhu, Qingbo Wang, Miaolin Zhu, Yun Chen, Bo Shen. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.788640
21	Mu-xing Li, Xin-yu Bi, Zhi-yu Li, Zhen Huang, Yue Han, Jian-guo Zhou, Jian-jun Zhao, Ye-fan Zhang, Hong Zhao, Jian-qiang Cai. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma. Medicine 2015; 94(49) doi: 10.1097/MD.0000000000002133
22	Ilze Strumfa, Dzeina Mezale, Boriss Strumfs, Andrejs Vanags, Arturs Kalva, Dainis Balodis, Ilze Fridrihsone, Arnis Abolins, Janis Gardovskis. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.76599
23	Leung Li, Stephen L. Chan, Frankie Mo, Edwin P. Hui, Jane Koh, Allen KC Chan, Nelson LS Tang, Cheuk M. Chu, Joyce Hui, Kit F. Lee, Simon Yu, Winnie Yeo. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Quality of Life Research 2019; 28(9) doi: 10.1007/s11136-019-02190-0
24	Ross D. Dolan, Donald C. McMillan. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score. Critical Reviews in Oncology/Hematology 2020; 150 doi: 10.1016/j.critrevonc.2020.102962